Evaluation of Hypertension Management and Cardiovascular Adverse Event Prevention in Patients With B-cell Malignancies Undergoing Treatment With Bruton Tyrosine Kinase Inhibitors, the HALT Study
Conditions: Chronic Lymphocytic Leukemia; Hematopoietic and Lymphoid System Neoplasm; Mantle Cell Lymphoma; Marginal Zone Lymphoma; Waldenstrom Macroglobulinemia Interventions: Other: Non-Interventional Study Sponsors: Mayo Clinic Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Cardiology | Cardiovascular | Chronic Leukemia | Chronic Lymphocytic Leukemia | Heart | Hypertension | Leukemia | Lymphoma | Macroglobulinemia | Research | Study | Waldenstrom's Macroglobulinemia